ASTRAZENECA PLC Form 6-K: Report of foreign private issuer
Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.
- 2014-04-24: Form 6-K; Period of report 2014-04-24; Description 1ST QUARTER RESULTS - PART 2; Document azn201404246k2.htm.
- 2014-04-24: Form 6-K; Period of report 2014-04-24; Description 1ST QUARTER RESULTS; Document azn201404246k.htm.
- 2014-04-23: Form 6-K; Period of report 2014-04-22; Description NOTICE OF RESULTS; Document azn201404236k.htm.
- 2014-04-01: Form 6-K; Period of report 2014-04-01; Description DIRECTOR/PDMR SHAREHOLDING; Document azn201404016k2.htm.
| Filed | Form | Period of report | Description | Document |
|---|---|---|---|---|
| 2014-04-24 | 6-K | 2014-04-24 | 1ST QUARTER RESULTS - PART 2 | azn201404246k2.htm |
| 2014-04-24 | 6-K | 2014-04-24 | 1ST QUARTER RESULTS | azn201404246k.htm |
| 2014-04-23 | 6-K | 2014-04-22 | NOTICE OF RESULTS | azn201404236k.htm |
| 2014-04-01 | 6-K | 2014-04-01 | DIRECTOR/PDMR SHAREHOLDING | azn201404016k2.htm |
| 2014-04-01 | 6-K | 2014-04-01 | TOTAL VOTING RIGHTS | azn201404016k.htm |
| 2014-03-31 | 6-K | 2014-03-31 | DIRECTOR/PDMR SHAREHOLDING | azn201403316k2.htm |
| 2014-03-31 | 6-K | 2014-03-31 | DIRECTOR/PDMR SHAREHOLDING | azn201403316k1.htm |
| 2014-03-31 | 6-K | 2014-03-31 | DIRECTOR/PDMR SHAREHOLDING | azn201403316k.htm |
| 2014-03-26 | 6-K | 2014-03-26 | DIRECTOR/PDMR SHAREHOLDING | azn201403266k.htm |
| 2014-03-21 | 6-K | 2014-03-20 | FILING OF ANNUAL REPORT ON FORM 20-F WITH SEC | azn201403216k.htm |
| 2014-03-20 | 6-K | 2014-03-20 | ANNUAL FINANCIAL REPORT | azn201403196k1.htm |
| 2014-03-20 | 6-K | 2014-03-20 | DIRECTORATE CHANGE | azn201403206k.htm |
| 2014-03-20 | 6-K | 2014-03-20 | FORM 6-K | dp44936_6k.htm |
| 2014-03-19 | 6-K | 2014-03-19 | DIRECTOR/PDMR SHAREHOLDING | azn201403196k.htm |
| 2014-03-12 | 6-K | 2014-03-12 | ASTRAZENECA ANNOUNCES SALE OF ALDERLEY PARK SITE | azn201403126k.htm |
| 2014-03-03 | 6-K | 2014-03-03 | TOTAL VOTING RIGHTS | azn201403036k2.htm |
| 2014-03-03 | 6-K | 2014-02-03 | US FDA APPROVES BYDUREON? PEN | azn201403036k.htm |
| 2014-02-25 | 6-K | 2014-02-25 | FDA APPROVES ORPHAN DRUG MYALEPT | azn201402256k.htm |
| 2014-02-12 | 6-K | 2014-02-12 | DIRECTOR/PDMR SHAREHOLDING | azn201402126k.htm |
| 2014-02-11 | 6-K | 2014-02-11 | DIRECTOR/PDMR SHAREHOLDING | azn201402116k.htm |
| 2014-02-10 | 6-K | 2014-02-10 | DIRECTOR/PDMR SHAREHOLDING | azn201402106k.htm |
| 2014-02-07 | 6-K | 2014-02-07 | DIRECTOR/PDMR SHAREHOLDING | azn201402076k.htm |
| 2014-02-06 | 6-K | 2014-02-06 | PIPELINE TABLE | azn201402066k1.htm |
| 2014-02-06 | 6-K | 2014-02-06 | FINAL RESULTS | azn201402066k.htm |
| 2014-02-05 | 6-K | 2014-02-05 | NOTICE OF RESULTS | azn201402056k.htm |
| 2014-02-03 | 6-K | 2014-02-03 | TOTAL VOTING RIGHTS | azn201402036k1.htm |
| 2014-02-03 | 6-K | 2014-02-03 | AZ COMPLETES BMS DIABETES ACQUISITION | azn201402036k.htm |
| 2014-01-27 | 6-K | 2014-01-27 | HOLDING(S) IN COMPANY | azn201401276k.htm |
| 2014-01-22 | 6-K | 2014-01-21 | XIGDUO APPROVED IN EU FOR TYPE 2 DIABETES | azn201401226k.htm |
| 2014-01-17 | 6-K | 2014-01-17 | BLOCK LISTING APPLICATION | azn201401166k.htm |
| 2014-01-14 | 6-K | 2014-01-14 | ASTRAZENECA PROVIDES STRATEGY UPDATE AT JP MORGAN | azn201401146k1.htm |
| 2014-01-13 | 6-K | 2014-01-09 | US FDA APPROVES FARXIGA? (DAPAGLIFLOZIN) | azn201401136k.htm |
| 2014-01-09 | 6-K | 2014-01-09 | US FDA APPROVAL OF FARXIGA (DAPAGLIFLOZIN) | azn201401096k.htm |
| 2014-01-02 | 6-K | 2014-01-02 | TOTAL VOTING RIGHTS | azn201401026k.htm |